← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-046 | 71506-046-45 | Labetalol Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-161 | 70092-161-43 | Methadone Hydrochloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:788 | 788 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-418 | 70092-418-36 | Midazolam Hydrochloride | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:788 | 788 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:789 | 789 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-125 | 63037-125-25 | Glycopyrrolate | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0050 | 71138-0050-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:789 | 789 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 77510-001 | 77510-001-01 | Isopropyl Alcohol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6478 | 71266-6478-3 | Iohexol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:789 | 789 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:789 | 789 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:789 | 789 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0211 | 71285-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-917 | 69194-917-01 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-009 | 70092-009-44 | Labetalol Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5417 | 72934-5417-2 | Lidocaine; Mupirocin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:789 | 789 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4604 | 72934-4604-8 | Minoxidil; Betamethasone Dipropionate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:789 | 789 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1036 | 73013-1036-1 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:790 | 790 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-164 | 82396-164-25 | Oxycodone Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:790 | 790 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-8233 | 62295-8233-4 | Isopropyl Alcohol | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6477 | 71266-6477-5 | Iohexol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:790 | 790 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:790 | 790 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:790 | 790 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0211 | 72196-0211-1 | Lidocaine Hydrochloride; Sodium Bicarbonate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Sodium Chloride; Sodium Gluconate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-919 | 69194-919-01 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:790 | 790 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5403 | 72934-5403-4 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6420 | 72682-6420-1 | Methionine; Inositol; Choline Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4610 | 72934-4610-8 | Minoxidil; Niacinamide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:790 | 790 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-198 | 63037-198-01 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:791 | 791 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0405 | 71285-0405-1 | Trophamine 3% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isopropyl Alcohol | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3135 | 62295-3135-5 | Iohexol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6622 | 71300-6622-5 | Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-023 | 71449-023-11 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Labetalol Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5595 | 26436-5595-3 | Methionine; Inositol; Choline Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:791 | 791 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methotrexate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4609 | 72934-4609-8 | Minoxidil; Progesterone | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:791 | 791 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:792 | 792 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2503 | 72934-2503-2 | Delibon | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0025 | 71138-0025-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9000 | 26436-9000-2 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:792 | 792 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1326 | 61141-1326-1 | Iopamidol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 33216-864 | 33216-864-00 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:792 | 792 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:792 | 792 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:792 | 792 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Phenylephrine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-024 | 71449-024-11 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-946 | 69374-946-34 | Labetalol Hydrochloride | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:792 | 792 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-2632 | 26436-2632-3 | Methionine; Inositol; Choline Chloride | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:792 | 792 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methotrexate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4602 | 72934-4602-8 | Minoxidil; Tretinoin; Fluocinolone Acetonide | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:792 | 792 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-521 | 70092-521-74 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:793 | 793 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71138-0375 | 71138-0375-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9021 | 26436-9021-4 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Dextrose Monohydrate; Histidine; Arginine; Taurine; Leucine; Methionine; Proline; Aspartic Acid | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0423 | 72196-0423-1 | Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5402 | 72934-5402-4 | Lidocaine; Tetracaine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5594 | 26436-5594-3 | Methionine; Inositol; Choline Chloride; Cyanocobalamin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methotrexate | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:793 | 793 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8475 | 71266-8475-3 | Mitomycin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:793 | 793 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:794 | 794 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8080 | 72682-8080-1 | Testosterone 80mg Pellet | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-9020 | 26436-9020-2 | Hydromorphone Hydrochloride; Bupivacaine Hydrochloride Related Compound A | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:794 | 794 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:794 | 794 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isopropyl Alcohol | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:794 | 794 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:794 | 794 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride; Tetracaine; Prilocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:794 | 794 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Levocarnitine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:794 | 794 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5596 | 26436-5596-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-006 | 67157-006-30 | Methylcobalamin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6412 | 71266-6412-3 | Mitomycin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:794 | 794 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:795 | 795 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5500 | 26436-5500-1 | Buprenorphine 0.4mg/mL PF | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:795 | 795 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:795 | 795 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0001 | 73271-0001-1 | Isopropyl Alcohol | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2010 | 71286-2010-3 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:795 | 795 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-2588 | 72682-2588-4 | Lidocaine; Tetracaine; Benzocaine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3101 | 72627-3101-1 | Lidocaine; Benzocaine; Tetracaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7427 | 72934-7427-6 | Levocetirizine Dihydrochloride; Clobetasol Propionate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:795 | 795 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-310 | 70092-310-46 | Methohexital Sodium | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6305 | 72682-6305-1 | Methylcobalamin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-103 | 81375-103-40 | Mitomycin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:795 | 795 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:796 | 796 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-617 | 70092-617-46 | Epinephrine 10 mcg/ml in 10 ml D5W syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-695 | 70004-695-31 | Isoproterenol Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Benzocaine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3100 | 72627-3100-1 | Lidocaine; Benzocaine; Tetracaine | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6006 | 71286-6006-1 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5401 | 72934-5401-4 | Lidocaine | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:796 | 796 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methotrexate | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6310 | 72682-6310-1 | Methylcobalamin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-100 | 81375-100-40 | Mitomycin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:796 | 796 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-519 | 70092-519-48 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:797 | 797 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-28 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2070 | 70168-2070-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2020-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-2:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-802 | 54288-802-01 | Isoproterenol Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lysine | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5405 | 72934-5405-4 | Lidocaine; Tetracaine; Benzocaine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1223 | 70657-1223-3 | Methylcobalamin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:797 | 797 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8515 | 71266-8515-3 | Mitomycin | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:797 | 797 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:798 | 798 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:798 | 798 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hyoscyamine Sulfate; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-068 | 71449-068-11 | Ketamine | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 54288-801 | 54288-801-10 | Isoproterenol Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:798 | 798 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0401 | 72196-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:798 | 798 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Epinephrine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:798 | 798 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:798 | 798 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine; Benzocaine | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1013 | 70657-1013-3 | Methylcobalamin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:798 | 798 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-242 | 73702-242-32 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:798 | 798 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-380 | 70092-380-36 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:799 | 799 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0620 | 70168-0620-1 | Testosterone Cypionate/Anastrozole 200/1mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ibutamoren Mesylate | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-2 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0401 | 71285-0401-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Glutamine; Arginine; Lysine | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1006 | 73271-1006-1 | Lidocaine; Tetracaine; Benzocaine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5015 | 26436-5015-3 | Methylcobalamin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:799 | 799 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:799 | 799 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-518 | 70092-518-75 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:800 | 800 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 84325-560 | 84325-560-14 | Nicotinamide Riboside Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Estradiol | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Idoxuridine | 2019-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2020-1:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9070 | 71266-9070-1 | Ketamine Hydrochloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Isoproterenol Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2013 | 71286-2013-2 | Hydromorphone Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3150 | 72627-3150-9 | Lidocaine; Prilocaine; Phenylephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9100 | 71266-9100-3 | Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Liraglutide | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 67157-006 | 67157-006-30 | Methylcobalamin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:800 | 800 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methylcobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-105 | 73177-105-01 | Morphine Sulfate | 2025-2 | valid | 0 | 2026-10-17 | |
outsourcing:2026-1:800 | 800 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:801 | 801 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone HCl | 2025-1 | valid | 0 | 2026-09-18 |